Clinical Trials Update: Jan. 7, 2005
Multiple Sclerosis Diabetic Neuropathy Obesity
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A research study for patients with relapsing-remitting or secondary progressive multiple sclerosis. Volunteers between ages 18 and 55 who have a diagnosis of active relapsing remitting or secondary progressive multiple sclerosis, and have had at least one relapse within 12 months of screening, may be eligible. Research sites located throughout the United States.
An experimental research study of an investigational medication taken twice daily for painful diabetic peripheral neuropathy. If you are at least 18 years old and have diabetic neuropathy, you may qualify for this study. Research site located in Englewood, NJ.
A research study to evaluate a new dietary supplement for its effectiveness on weight loss and its ability to satisfy hunger. Healthy volunteers between ages 18 and 65 may be eligible for this 12-week study. Research sites located in Huntington, NY, and Great Neck, NY.
Copyright 2005 CenterWatch. All rights reserved.